Nexvet is a veterinary biologics developer focused on creating novel, species-specific therapeutics for companion animals like dogs and cats. Our proprietary PETization™ platform enables rapid design of monoclonal antibodies that are recognized as 'self' or 'native' by an animal's immune system, red...See more
Headquarter Ireland |
Countries of operation Australia, Ireland |
Year founded 2010 (14 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Research Scientist
Chief Scientific Officer
Principal Scientist